Updated Jul. 1, 2013 at 6:16 p.m.

Premium Lock Tengion closes on $33.6M to continue regenerative medicine R&D

Published: 2013-07-01 18:11:00
Updated: 2013-07-01 18:16:59

Print this blog post
Tengion Tengion

Regenerative medicine firm Tengion (OTC:TNGN) has found a way to generate something that has been in short supply for the company: the funding needed to continue R&D work and clinical trials on novel technology for regenerating human tissue....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll